Cancer

Short Description: 
Learn the facts about women, cancer, and hormones. Reduce your risk of cancer through proper nutrition, daily fitness, and bioidentical hormones.

Cancer and Women
The statistics surrounding cancer in women are harrowing. The National Cancer Institute estimates that 774,370 women were diagnosed with cancer in 2011 alone, and more than 500,000 Americans die of cancer every year. What's more-- about 230,480 women were diagnosed with breast cancer and 39,520 women died of breast cancer in 2011.

The good news on cancer? Reducing your risk of cancer can be done through proper nutrition, daily fitness, and in some cases the use of bioidentical hormone replacement therapy.

Exercise, for example, is known to reduce the amount of estrogen circulating in the system, and estrogens are known to decrease the rate at which the cancers cells die off, such as breast and prostate cancers.

Nutritional ways to prevent cancer include diets that are low in fat, high in fiber, less red meat, and more seafood, as well as a diet that is high in antioxidants.

Studies show hormones can play a role in the cancer prevention and many controversial media reports pushed by the pharmaceutical companies send mixed messages, making it difficult for the public to make informed and objective decisions.

Testosterone: The Anti-Breast Cancer Hormone for Women
It may surprise you to learn that testosterone is actually an anti-breast cancer hormone for women, and it's gaining attention of the medical community. Menopausal women using testosterone can prevent hormone deficiency symptoms such as hot flashes, sleep disturbances, and other symptoms of hormone deficiency, as well as reduce the rate of breast cancer.

According to a recent study, post menopausal women who took estrogen plus testosterone hormones had a lower breast cancer rate than the group of women who did not take any hormones.

  • Breast Cancer rate of 115 per 100,000 women years for estrogen plus testosterone
  • Breast Cancer rate of 283 per 100,000 women years for women who never took hormones

STUDY: (Dimitrakakis C, Jones RA, Liu A and Bondy CA, Menopause, 2004, 11:531-535. Breast cancer incidence in postmenopausal women using testosterone in addition to usual hormone therapy.)

"We believe testosterone is beneficial to breast tissue," states Rebecca Glaser, MD, a researcher on testosterone therapy by pellet implant, its impact on men and women's health and breast cancer prevention. Dr. Glasser treats menopausal women without breast cancer as well as women with breast cancer history.

Although treating menopausal women with testosterone is gaining popularity and supporting evidence validates its potential, Chicago's Ageology physicians emphasize the importance of seeking the care of a qualified bioidentical hormone therapy physician who offers proper evaluation, diagnosis and follow up. Other hormones that are important for a woman's overall health and may convey some protection to the breast tissue include progesterone and estriol.

Progesterone: The Balancer
The risk of breast cancer for women who took estrogen plus bioidentical progesterone was the same as for women who never took hormones.

  • 318/100,000 women years for estrogen plus progesterone
  • 313/100,000 women years for control
  • 505/100,000 women years for estrogen plus fake progesterone

Estriol: The Estrogen That Protects
Estriol is one of the many estrogens that a woman produces throughout her life.  As a woman ages, the levels of estriol decline.  Estriol provides protection to breast tissue by blocking the direct effect of estradiol, the most potent of the estrogens. Studies prove that higher levels of estriol are correlated with a lower rate of breast cancer.

Subscribe to Ageology to stay in touch with the best practices in nutrition, fitness, health, and hormones, or contact a Chicago-based Ageology physician to learn more!

The Women's Health Initiative 2004 - Review and Critique

A must read critique of the Women’s Health Initiative, the study that changed the manner in which physicians view hormone replacement therapy.

Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort

The E3N-EPIC cohort of 2004 indicates that the association between hormone replacement and breast cancer risk most likely varies according to the type of synthetic progesterone used. There was no or little increase in risk with estrogens used alone or combined with micronized (bioidentical) progesterone.

Low salivary testosterone levels in patients with breast cancer

Salivary testosterone levels are significantly lower in women with breast cancer compared to age-matched control women. These findings support the protective role of bioavailable testosterone in counteracting the proliferative effects of estrogens on mammary tissue.

Exemestane for breast-cancer prevention in postmenopausal women

Exemestane (Aromasin) significantly reduced invasive breast cancers in postmenopausal women who were at moderately increased risk for breast cancer. During a median follow-up period of 3 years, exemestane was associated with no serious toxic effects and only minimal changes in health-related quality of life.

What your doctor may not tell you about breast cancer

call now

Take the first step to better health. Speak to a representative to see a doctor near you!

Call now (312) 255-9763